Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ketoconazole and Quinine

supplement:

Quinine

Research Papers that Mention the Interaction

Ketoconazole , a potent inhibitor of CYP3A4, is known to markedly increase plasma concentrations of various co‐administered drugs including quinine.
Journal of clinical pharmacy and therapeutics  •  2005  |  View Paper
KTZ enhanced the therapeutic antischistosomal potential of QN and HF over each drug alone.
KTZ plus QN or HF produced more inhibition (P<0.05) in hepatic CYP450 (85.7% and 83.8%) and CYT b5 (75.5% and 73.5%) activities, respectively, than in groups treated with QN or HF alone.
QN and HF significantly (P<0.05) elevated malondialdehyde levels when used alone or with KTZ.
The Korean journal of parasitology  •  2013  |  View Paper
Ketoconazole and troleandomycin inhibited the 3-hydroxylation of quinine in all species.
The Journal of pharmacology and experimental therapeutics  •  1997  |  View Paper
When the plasma/serum concentrations possibly attained after their usual therapeutic doses were taken into account, tetracycline, doxycycline, omeprazole, ketoconazole , nifedipine, troleandomycin and erythromycin are likely to be inhibitors of quinine metabolism in patients when these drugs are co-administrated with quinine.
European Journal of Drug Metabolism and Pharmacokinetics  •  2010  |  View Paper
KTZ racemate and enantiomers showed differential inhibitory effects of quinine and alprazolam metabolism.
Quinine metabolism catalyzed by HLM, CYP3A4 and CYP3A5 was potently inhibited by the trans-enantiomer KTZ 2S,4S, with IC50 value of 0.16 μM for HLM, 0.04 μM for CYP3A4 and 0.11 μM for CYP3A5.
European Journal of Clinical Pharmacology  •  2006  |  View Paper
Two inhibitors of CYP3A4, ketoconazole (1 microM) and troleandomycin (100 microM), inhibited quinine 3-hydroxylation by about 90% and 80%, and etoposide 3'-demethylation by about 75% and 65%, respectively.
Drug metabolism and disposition: the biological fate of chemicals  •  1998  |  View Paper
Ketoconazole and troleandomycin (inhibitors of … the 3-hydroxylation of quinine by human liver microsomes with respective mean IC50 values of 0.026 microM and 28.9 microM. Anti-CYP3A antibodies … inhibited quinine 3-hydroxylation, whereas weak inhibition was observed in the presence of S-mephenytoin or anti-CYP2C antibodies.
The Journal of pharmacology and experimental therapeutics  •  1996  |  View Paper